{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:43:11Z","timestamp":1773236591936,"version":"3.50.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.arcmed.2009.07.007","type":"journal-article","created":{"date-parts":[[2009,10,22]],"date-time":"2009-10-22T08:57:19Z","timestamp":1256201839000},"page":"486-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Innovation in Cervical Cancer Prevention and Control in Mexico"],"prefix":"10.1016","volume":"40","author":[{"given":"Eduardo","family":"Lazcano-Ponce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betania","family":"Allen-Leigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2009.07.007_bib1","first-page":"63","article-title":"Social inequities along the cervical cancer continuum: a structured review","volume":"16","author":"Newmann","year":"2005","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.arcmed.2009.07.007_bib2","first-page":"1092","article-title":"Measures of racial\/ethnic health disparities in cancer mortality rates and the influence of socioeconomic status","volume":"99","author":"Chu","year":"2007","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.arcmed.2009.07.007_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1748-0361.2005.tb00075.x","article-title":"Geographic disparities in cervical cancer mortality: what are the roles of risk factor prevalence, screening, and use of recommended treatment?","volume":"21","author":"Yabroff","year":"2005","journal-title":"J Rural Health"},{"key":"10.1016\/j.arcmed.2009.07.007_bib4","first-page":"78","article-title":"Cancer disparities by race\/ethnicity and socioeconomic status","volume":"54","author":"Ward","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.arcmed.2009.07.007_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1440-1584.2003.00464.x","article-title":"Abnormal Pap test results and the rurality factor","volume":"11","author":"Dietsch","year":"2003","journal-title":"Aust J Rural Health"},{"key":"10.1016\/j.arcmed.2009.07.007_bib6","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/jnci\/84.13.1030","article-title":"Incidence of dysplasia and carcinoma of the uterine cervix in an Appalachian population","volume":"84","author":"Friedell","year":"1992","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.arcmed.2009.07.007_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/PHH.0b013e3181a117da","article-title":"Trends in cervical and breast cancer screening practices among women in rural and urban areas of the United States","volume":"15","author":"Doescher","year":"2009","journal-title":"J Public Health Manag Pract"},{"key":"10.1016\/j.arcmed.2009.07.007_bib8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5694\/j.1326-5377.2006.tb00663.x","article-title":"Participation in cervical screening by indigenous women in the Northern Territory: a longitudinal study","volume":"185","author":"Binns","year":"2006","journal-title":"Med J Aust"},{"key":"10.1016\/j.arcmed.2009.07.007_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1479-828X.2001.tb01237.x","article-title":"Variation in cervical cancer screening by region, socio-economic, migrant and indigenous status in women in New South Wales","volume":"41","author":"Wain","year":"2001","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"10.1016\/j.arcmed.2009.07.007_bib10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.5694\/j.1326-5377.2002.tb04949.x","article-title":"Participation in cervical cancer screening by women in rural and remote Aboriginal and Torres Strait Islander communities in Queensland","volume":"177","author":"Coory","year":"2002","journal-title":"Med J Aust"},{"issue":"suppl 3","key":"10.1016\/j.arcmed.2009.07.007_bib11","doi-asserted-by":"crossref","first-page":"S315","DOI":"10.1590\/S0036-36342003000900005","article-title":"Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico","volume":"45","author":"Palacio-Mej\u00eda","year":"2003","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.arcmed.2009.07.007_bib12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1055-9965.EPI-04-0569","article-title":"Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening","volume":"14","author":"Bray","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"suppl 9","key":"10.1016\/j.arcmed.2009.07.007_bib13","first-page":"1","article-title":"Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017","volume":"36","author":"Hristova","year":"1997","journal-title":"Acta Oncol"},{"key":"10.1016\/j.arcmed.2009.07.007_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(04)16674-9","article-title":"The cervical cancer epidemic that screening has prevented in the UK","volume":"364","author":"Peto","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2009.07.007_bib15","first-page":"954","article-title":"Effective screening programmes for cervical cancer in low- and middle-income developing countries","volume":"79","author":"Sankaranarayanan","year":"2001","journal-title":"Bull World Health Organ"},{"issue":"suppl 10","key":"10.1016\/j.arcmed.2009.07.007_bib16","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26","author":"Cuzick","year":"2008","journal-title":"Vaccine"},{"issue":"suppl 10","key":"10.1016\/j.arcmed.2009.07.007_bib17","doi-asserted-by":"crossref","first-page":"K42","DOI":"10.1016\/j.vaccine.2008.05.002","article-title":"New technologies in cervical cancer screening","volume":"26","author":"Gravitt","year":"2008","journal-title":"Vaccine"},{"issue":"suppl 11","key":"10.1016\/j.arcmed.2009.07.007_bib18","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1016\/j.vaccine.2008.05.043","article-title":"Burden and trends of type-specific human papillomavirus infections and related diseases in the Latin American and Caribbean region","volume":"26","author":"Parkin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2009.07.007_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase 11 efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.arcmed.2009.07.007_bib20","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"issue":"suppl 2","key":"10.1016\/j.arcmed.2009.07.007_bib21","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1590\/S0036-36342009000800011","article-title":"Diferencias regionales en la mortalidad por c\u00e1ncer de mama y c\u00e9rvix en M\u00e9xico entre 1979 y 2006","volume":"51","author":"Palacio-Mej\u00eda","year":"2009","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.arcmed.2009.07.007_bib22","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1158\/1055-9965.EPI-07-2659","article-title":"Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology","volume":"17","author":"Lazcano-Ponce","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.arcmed.2009.07.007_bib23","first-page":"505","article-title":"Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico","volume":"14","author":"Salmer\u00f3n","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.arcmed.2009.07.007_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/cncr.22487","article-title":"Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS)","volume":"111","author":"Eltoum","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.arcmed.2009.07.007_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jnci\/95.1.46","article-title":"Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10 year cohort analysis","volume":"95","author":"Sherman","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.arcmed.2009.07.007_bib26","doi-asserted-by":"crossref","DOI":"10.5858\/2008-132-1290-HPTARR","article-title":"Human papillomavirus testing and reporting rates: practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology in 2006","volume":"132","author":"Moriarty","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"suppl 1","key":"10.1016\/j.arcmed.2009.07.007_bib27","first-page":"S71","article-title":"Methods for detection of HPV infection and its clinical utility","volume":"94","author":"Villa","year":"2006","journal-title":"Int J Gyn Obstet"},{"key":"10.1016\/j.arcmed.2009.07.007_bib28","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1016\/j.vaccine.2007.01.016","article-title":"Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening","volume":"25","author":"Adams","year":"2007","journal-title":"Vaccine"},{"issue":"suppl 11","key":"10.1016\/j.arcmed.2009.07.007_bib29","doi-asserted-by":"crossref","first-page":"L49","DOI":"10.1016\/j.vaccine.2008.05.025","article-title":"New approaches to cervical cancer screening in Latin America and the Caribbean","volume":"26","author":"Herrero","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2009.07.007_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/sti.2004.011858","article-title":"Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis","volume":"81","author":"Ogilvie","year":"2005","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.arcmed.2009.07.007_bib31","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1089\/jwh.2005.14.721","article-title":"Acceptability of self-collection of specimens for HPV DNA testing in an urban population","volume":"14","author":"Anhang","year":"2005","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.arcmed.2009.07.007_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/152460902753668466","article-title":"The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening","volume":"11","author":"Dzuba","year":"2002","journal-title":"J Womens Health Gend Based Med"},{"key":"10.1016\/j.arcmed.2009.07.007_bib33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/096914130601300409","article-title":"Acceptability of unsupervised HPV self-sampling using written instructions","volume":"13","author":"Waller","year":"2006","journal-title":"J Med Screen"},{"key":"10.1016\/j.arcmed.2009.07.007_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/01674820802076038","article-title":"Discussions about self-obtained samples for HPV testing as an alternative for cervical cancer prevention","volume":"29","author":"Barata","year":"2008","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.arcmed.2009.07.007_bib35","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1080\/00016340701303747","article-title":"Attitudes to self-sampling of vaginal smear for human papilloma virus analysis among women not attending organized cytological screening","volume":"86","author":"Wikstr\u00f6m","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.arcmed.2009.07.007_bib36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0188-0128(99)00006-8","article-title":"Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico","volume":"30","author":"Lazcano-Ponce","year":"1999","journal-title":"Arch Med Res"},{"key":"10.1016\/j.arcmed.2009.07.007_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000332512","article-title":"Validity and reproducibility of cytologic diagnosis in a sample of cervical cancer screening centers in Mexico","volume":"41","author":"Lazcano-Ponce","year":"1997","journal-title":"Acta Cytol"},{"key":"10.1016\/j.arcmed.2009.07.007_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/dc.2840100104","article-title":"Quality control study on negative gynecological cytology in Mexico","volume":"10","author":"Lazcano-Ponce","year":"1994","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.arcmed.2009.07.007_bib39","first-page":"291","article-title":"Random rescreening of cytologic smears: a practical and effective component of quality assurance programs in both large and small cytology laboratories","volume":"38","author":"Krieger","year":"1994","journal-title":"Acta Cytol"},{"key":"10.1016\/j.arcmed.2009.07.007_bib40","first-page":"241","article-title":"Evaluation model of the Mexican national program for early cervical cancer detection and proposals for a new approach","volume":"9","author":"Lazcano-Ponce","year":"1998","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.arcmed.2009.07.007_bib41","first-page":"637","article-title":"Overuse of colposcopy service in Mexico","volume":"73","author":"Madrigal de la Campa Mde","year":"2005","journal-title":"Ginecol Obstet Mex"},{"key":"10.1016\/j.arcmed.2009.07.007_bib42","first-page":"658","article-title":"Colposcopy 101: a didactic curriculum to complement the clinical experience","volume":"33","author":"Deizell","year":"2001","journal-title":"Fam Med"},{"key":"10.1016\/j.arcmed.2009.07.007_bib43","first-page":"590","article-title":"Development of a curriculum in colposcopy","volume":"32","author":"Caruthers","year":"1991","journal-title":"J Fam Pract"},{"key":"10.1016\/j.arcmed.2009.07.007_bib44","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1067\/mob.2001.115993","article-title":"Residency training in colposcopy: a survey of program directors in obstetrics and gynecology and family practice","volume":"185","author":"Spitzer","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.arcmed.2009.07.007_bib45","first-page":"350","article-title":"Assessing colposcopic skills: the instructor's handbook","volume":"30","author":"Brotzman","year":"1998","journal-title":"Fam Med"},{"issue":"suppl 3","key":"10.1016\/j.arcmed.2009.07.007_bib46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vaccine.2006.06.016","article-title":"Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays\u2013an update","volume":"24","author":"Pagliusi","year":"2006","journal-title":"Vaccine"},{"issue":"7 suppl","key":"10.1016\/j.arcmed.2009.07.007_bib47","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/cncr.23704","article-title":"Human papillomavirus infection and the primary and secondary prevention of cervical cancer","volume":"113","author":"Lowy","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.arcmed.2009.07.007_bib48","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/ijc.23839","article-title":"Test positivity cutoff level of a high risk human papillomavirus test could be increased in routine cervical cancer screening","volume":"123","author":"Kotaniemi-Talonen","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.arcmed.2009.07.007_bib49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-6413-4-16","article-title":"Barriers to adoption of recent technology in cervical screening","volume":"4","author":"Jhala","year":"2007","journal-title":"Cytojournal"},{"key":"10.1016\/j.arcmed.2009.07.007_bib50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jncimonographs\/lgi037","article-title":"Breast and cervical cancer screening: clinicians' views on health plan guidelines and implementation efforts","volume":"35","author":"Zapka","year":"2005","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.arcmed.2009.07.007_bib51","first-page":"745","article-title":"Implementation of systems strategies for breast and cervical cancer screening services in health maintenance organizations","volume":"9","author":"Goins","year":"2003","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.arcmed.2009.07.007_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-4755-2-11","article-title":"A strategic assessment of cervical cancer prevention and treatment services in 3 districts of Uttar Pradesh","volume":"2","author":"Dabash","year":"2005","journal-title":"India. Reprod Health"},{"key":"10.1016\/j.arcmed.2009.07.007_bib53","first-page":"75","article-title":"Mexico City physicians' awareness about cervical cancer prevention: implications for cancer screening","volume":"16","author":"Arillo-Santillan","year":"2001","journal-title":"J Cancer Educ"},{"key":"10.1016\/j.arcmed.2009.07.007_bib54","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10903-007-9076-4","article-title":"Cancer screening and Haitian immigrants: the primary care provider factor","volume":"10","author":"Gany","year":"2008","journal-title":"J Immigr Minor Health"},{"key":"10.1016\/j.arcmed.2009.07.007_bib55","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1748-0361.2004.tb00051.x","article-title":"Barriers to cancer screening by rural Appalachian primary care providers","volume":"20","author":"Shell","year":"2004","journal-title":"J Rural Health"},{"key":"10.1016\/j.arcmed.2009.07.007_bib56","first-page":"160","article-title":"Primary care physicians' knowledge, attitudes and practices related to cancer screening and cancer prevention clinical trials","volume":"11","author":"Ka'ano'i","year":"2004","journal-title":"Pac Health Dialog"},{"key":"10.1016\/j.arcmed.2009.07.007_bib57","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ypmed.2005.09.010","article-title":"Primary care physicians' awareness and adherence to cervical cancer screening guidelines in Texas","volume":"42","author":"Holland-Barkis","year":"2006","journal-title":"Prev Med"},{"key":"10.1016\/j.arcmed.2009.07.007_bib58","first-page":"265","article-title":"Primary care practice and facility quality orientation: influence on breast and cervical cancer screening rates","volume":"10","author":"Goldzweig","year":"2004","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.arcmed.2009.07.007_bib59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/152460901300039584","article-title":"Rural physicians' perspectives on cervical and breast cancer screening: a gender-based analysis","volume":"10","author":"Ahmad","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"key":"10.1016\/j.arcmed.2009.07.007_bib60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1100\/tsw.2007.50","article-title":"Physician satisfaction in a cancer prevention program for low-income women in Nevada","volume":"7","author":"Cochran","year":"2007","journal-title":"Sci World J"},{"key":"10.1016\/j.arcmed.2009.07.007_bib61","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1100\/tsw.2006.151","article-title":"Factors for satisfaction among providers of ancillary health services in a community-based cancer prevention program: a pilot study in Nevada","volume":"6","author":"Gorospe","year":"2006","journal-title":"Sci World J"},{"key":"10.1016\/j.arcmed.2009.07.007_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001271.pub2","article-title":"Substitution of doctors by nurses in primary care","author":"Laurant","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcmed.2009.07.007_bib63","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2648.2008.04888.x","article-title":"Nurse practitioners substituting for general practitioners: randomized controlled trial","volume":"65","author":"Dierick-van Daele","year":"2009","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.arcmed.2009.07.007_bib64","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/bmj.324.7341.819","article-title":"Systematic review of whether nurse practitioners working in primary care can provide equivalent care to doctors","volume":"324","author":"Horrocks","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.arcmed.2009.07.007_bib65","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0968-8080(08)32411-2","article-title":"Making the case for cervical cancer prevention: what about equity?","volume":"16","author":"Tsu","year":"2008","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.arcmed.2009.07.007_bib66","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0968-8080(08)32409-4","article-title":"Benefits, cost requirements and cost-effectiveness of the HPV16, 18 vaccine for cervical cancer prevention in developing countries: policy implications","volume":"16","author":"Goldie","year":"2008","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.arcmed.2009.07.007_bib67","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/ijc.23260","article-title":"Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women","volume":"122","author":"Perez","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.arcmed.2009.07.007_bib68","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","article-title":"Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials","volume":"369","author":"Joura","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2009.07.007_bib69","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2009.07.007_bib70","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial","volume":"298","author":"Hildesheim","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.arcmed.2009.07.007_bib71","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1086\/521679","article-title":"Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine","volume":"196","author":"Giuliano","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.arcmed.2009.07.007_bib72","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.inf.0000253970.29190.5a","article-title":"Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial","volume":"26","author":"Reisinger","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"suppl 10","key":"10.1016\/j.arcmed.2009.07.007_bib73","doi-asserted-by":"crossref","first-page":"K53","DOI":"10.1016\/j.vaccine.2008.06.002","article-title":"An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results","volume":"26","author":"Schiller","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2009.07.007_bib74","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/jmv.21282","article-title":"Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5 year longitudinal study in a routine cytology-based screening population in West Germany","volume":"80","author":"Kov\u00e1cs","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.arcmed.2009.07.007_bib75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/00016340802566770","article-title":"The efficacy of HPV 16\/18 vaccines on sexually active 18\u201323 year old women and the impact of HPV vaccination on organized cervical cancer screening","volume":"88","author":"Sigurdsson","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.arcmed.2009.07.007_bib76","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1503\/cmaj.070948","article-title":"Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials","volume":"177","author":"Rambout","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.arcmed.2009.07.007_bib77","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4161\/hv.4.6.6912","article-title":"Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16\/18 cervical cancer vaccine","volume":"4","author":"Dessy","year":"2008","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.arcmed.2009.07.007_bib78","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1016\/j.vaccine.2008.06.045","article-title":"The potential health and economic benefits of preventing recurrent respiratory papillomatosis through quadrivalent human papillomavirus vaccination","volume":"26","author":"Chesson","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.arcmed.2009.07.007_bib79","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.oraloncology.2008.07.008","article-title":"Oropharyngeal carcinoma in non-smokers and non-drinkers: a role for HPV","volume":"45","author":"Andrews","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.arcmed.2009.07.007_bib80","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jcv.2008.09.009","article-title":"Betapapillomaviruses: innocent bystanders or causes of skin cancer","volume":"43","author":"Feltkamp","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1016\/j.arcmed.2009.07.007_bib81","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1185\/03007990802068151","article-title":"Future II Study Group. Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6\/11\/16\/18) vaccine clinical trials","volume":"24","author":"Paavonen","year":"2008","journal-title":"Curr Med Res Opin"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440909001337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440909001337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:37:05Z","timestamp":1759261025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440909001337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0188440909001337"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2009.07.007","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovation in Cervical Cancer Prevention and Control in Mexico","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2009.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}